Loading: 100%
BOSTON SCIENTIFIC CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Marlborough, United States of AmericaMarlborough, United States of Americano data available
Employees 27,000 (as per Q1 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker BSXno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1720,022,525,027,530,0
datesClosing price (adj.)
13.10.201729.44
11.10.201729.27
04.10.201729.24
27.09.201728.86
20.09.201728.84
13.09.201729.08
06.09.201728.22
30.08.201727.08
23.08.201726.84
16.08.201726.68
09.08.201726.57
02.08.201726.51
26.07.201727.42
19.07.201727.93
12.07.201727.82
05.07.201727.63
27.06.201727.81
20.06.201728.01
13.06.201727.92
06.06.201727.50
30.05.201727.36
23.05.201726.67
16.05.201726.48
09.05.201726.38
02.05.201726.59
25.04.201725.74
18.04.201724.47
11.04.201724.57
04.04.201724.63
28.03.201724.70
21.03.201724.14
14.03.201724.43
07.03.201724.48
28.02.201724.55
21.02.201725.28
14.02.201725.18
07.02.201725.23
31.01.201724.06
24.01.201723.54
17.01.201723.90
10.01.201723.61
03.01.201721.88
27.12.201621.76
19.12.201621.47
12.12.201621.09
05.12.201620.71
28.11.201620.75
21.11.201621.46
14.11.201620.79
07.11.201622.04
31.10.201622.00
24.10.201622.97
17.10.201622.82
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
29.44n/a
Market Capitalisation
in million USD
40,315n/a
Enterprise Value
in million USD
45,503n/a
Common Shares Outstanding
as per Apr 28, 2017
1,369,401,733n/a
Preferred Shares Outstanding
as per Apr 28, 2017
n/a
Average Basic Shares Outstanding
TTM
1,361,350,000n/a
Average Diluted Shares Outstanding
TTM
1,382,275,000n/a
Index Membership
n/a
Business Summary
Boston Scientific Corp is a developer, manufacturer and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 8,173n/a
Gross Profit 5,794n/a
Operating Income 1,240n/a
EBITDA 0n/a
Net Profit 81n/a
Balance Sheet
Cash and Cash Equivalents 237n/a
Receivables 1,385n/a
Total Current Assets 3,181n/a
PP&E 1,500n/a
Total Assets 17,697n/a
Accounts Payable 298n/a
Current Debt 254n/a
Total Current Liabilities 3,016n/a
Long-Term Debt 5,171n/a
Total Liabilities 11,215n/a
Total Equity 6,482n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 70.9%n/a
Operating Margin 15.2%n/a
Net Profit Margin 1.0%n/a
Return on Equity 1.3%n/a
Return on Assets 0.5%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 5.57n/a
Book to Market Value 0.16n/a
Other Ratios
Current Ratio 105.5%n/a
Liabilities to Equity Ratio 173.0%n/a
Debt to Assets Ratio 30.7%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
8,357
8,050
8,188
7,806
7,622
7,249
7,143
7,380
7,477
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-2,342
-2,469
-2,576
-2,599
-2,659
-2,349
-2,174
-2,210
-2,173
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
6,015
5,581
5,612
5,207
4,963
4,900
4,969
5,170
5,304
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-4,620
-4,138
-4,181
-4,034
-3,810
-3,810
-3,949
-4,072
-4,367
Selling, General & Administrative
-2,909
-2,589
-2,635
-2,580
-2,487
-2,535
-2,674
-2,902
-2,873
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-1,091
-1,006
-1,035
-939
-895
-886
-861
-817
-876
Depreciation & Amortization
-620
-543
-511
-513
-421
-395
-410
-438
-495
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
-2
-7
6
-4
85
-123
Operating Income (Loss)
1,395
1,443
1,431
1,173
1,153
1,090
1,020
1,098
937
Non-Operating Income (Loss)
-757
-729
-605
-592
-434
-392
-483
-319
-393
Interest Expense, net
-570
-468
-407
-393
-281
-261
-324
-216
-284
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-187
-261
-198
-199
-153
-131
-159
-103
-109
Pretax Income (Loss), Adjusted
638
714
826
581
719
698
537
779
544
Abnormal Gains (Losses)
-1,207
-2,745
-2,134
-1,644
-77
-4,805
-760
-1,288
-1,194
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-569
-2,031
-1,308
-1,063
642
-4,107
-223
-509
-650
Income Tax (Expense) Benefit, net
74
-5
283
-2
-201
39
102
390
411
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-495
-2,036
-1,025
-1,065
441
-4,068
-121
-119
-239
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-495
-2,036
-1,025
-1,065
441
-4,068
-121
-119
-239
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
-495
-2,036
-1,025
-1,065
441
-4,068
-121
-119
-239
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-495
-2,036
-1,025
-1,065
441
-4,068
-121
-119
-239
Remarks
restated on Feb 26, 2010 n/a
calculated values,
restated on Feb 17, 2011 n/a
calculated values,
restated on Feb 17, 2012 n/a
calculated values,
restated on Feb 22, 2013 n/a
calculated values,
restated on Feb 26, 2014 n/a
calculated values,
restated on Feb 25, 2015 n/a
calculated values,
restated on Feb 24, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
1,641
864
213
267
207
217
587
319
Cash & Cash Equivalents
n/a
1,641
864
213
267
207
217
587
319
Short Term Investments
n/a
0
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
1,402
1,375
1,320
1,246
1,217
1,307
1,183
1,275
Accounts Receivable, Net
n/a
1,402
1,375
1,320
1,246
1,217
1,307
1,183
1,275
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
853
891
894
931
884
897
946
1,016
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
1,556
1,469
1,188
661
714
590
890
861
Prepaid Expenses
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
578
576
0
0
0
0
0
Deferred Tax Assets
n/a
911
572
429
458
433
288
447
496
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
645
319
183
203
281
302
443
365
Total Current Assets
n/a
5,452
4,599
3,615
3,105
3,022
3,011
3,606
3,471
Property, Plant & Equipment, Net
n/a
1,728
1,722
1,697
1,670
1,564
1,546
1,507
1,490
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
19,959
18,856
16,816
16,515
12,568
12,014
11,911
13,172
Intangible Assets
n/a
0
0
0
0
0
0
0
0
Goodwill
n/a
12,421
11,936
10,186
9,761
5,973
5,693
5,898
6,473
Other Intangible Assets
n/a
7,244
6,667
6,343
6,473
6,289
5,950
5,606
6,194
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
294
253
287
281
306
371
407
505
Total Noncurrent Assets
n/a
21,687
20,578
18,513
18,185
14,132
13,560
13,418
14,662
Total Assets
n/a
27,139
25,177
22,128
21,290
17,154
16,571
17,024
18,133
Liabilities and owners' equity
Payables & Accruals
n/a
2,851 2851000000
2,821 2821000000
1,810 1810000000
1,530 1530000000
1,516 1516000000
1,594 1594000000
2,212 2212000000
2,179 2179000000
Accounts Payable
n/a
239 239000000
212 212000000
184 184000000
203 203000000
232 232000000
246 246000000
262 262000000
209 209000000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
2,612 2612000000
2,609 2609000000
1,626 1626000000
1,327 1327000000
1,284 1284000000
1,348 1348000000
1,950 1950000000
1,970 1970000000
Short Term Debt
n/a
2 2000000
3 3000000
504 504000000
4 4000000
4 4000000
3 3000000
403 403000000
3 3000000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
380 380000000
198 198000000
295 295000000
273 273000000
252 252000000
227 227000000
231 231000000
248 248000000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
380 380000000
198 198000000
295 295000000
273 273000000
252 252000000
227 227000000
231 231000000
248 248000000
Total Current Liabilities
n/a
3,233 3233000000
3,022 3022000000
2,609 2609000000
1,807 1807000000
1,772 1772000000
1,824 1824000000
2,846 2846000000
2,430 2430000000
Long Term Debt
n/a
6,743 6743000000
5,915 5915000000
4,934 4934000000
4,257 4257000000
4,252 4252000000
4,237 4237000000
3,841 3841000000
5,674 5674000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
3,989 3989000000
3,939 3939000000
3,289 3289000000
3,873 3873000000
4,260 4260000000
3,971 3971000000
3,880 3880000000
3,709 3709000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
2,262 2262000000
1,875 1875000000
1,644 1644000000
1,865 1865000000
1,713 1713000000
1,402 1402000000
1,214 1214000000
735 735000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
1,727 1727000000
2,064 2064000000
1,645 1645000000
2,008 2008000000
2,547 2547000000
2,569 2569000000
2,666 2666000000
2,974 2974000000
Total Noncurrent Liabilities
n/a
10,732 10732000000
9,854 9854000000
8,223 8223000000
8,130 8130000000
8,512 8512000000
8,208 8208000000
7,721 7721000000
9,383 9383000000
Total Liabilities
n/a
13,965 13965000000
12,876 12876000000
10,832 10832000000
9,937 9937000000
10,284 10284000000
10,032 10032000000
10,567 10567000000
11,813 11813000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
15,959 15959000000
16,101 16101000000
16,247 16247000000
16,364 16364000000
16,444 16444000000
16,595 16595000000
16,719 16719000000
16,876 16876000000
Common Stock
n/a
15 15000000
15 15000000
15 15000000
15 15000000
15 15000000
16 16000000
16 16000000
16 16000000
Additional Paid in Capital
n/a
15,944 15944000000
16,086 16086000000
16,232 16232000000
16,349 16349000000
16,429 16429000000
16,579 16579000000
16,703 16703000000
16,860 16860000000
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
-492 -492000000
-1,092 -1092000000
-1,592 -1592000000
-1,717 -1717000000
-1,717 -1717000000
Retained Earnings
n/a
-2,732 -2732000000
-3,757 -3757000000
-4,822 -4822000000
-4,381 -4381000000
-8,449 -8449000000
-8,570 -8570000000
-8,689 -8689000000
-8,927 -8927000000
Other Equity
n/a
-53 -53000000
-43 -43000000
-129 -129000000
-138 -138000000
-33 -33000000
106 106000000
144 144000000
88 88000000
Equity Before Minority Interest
n/a
13,174 13174000000
12,301 12301000000
11,296 11296000000
11,353 11353000000
6,870 6870000000
6,539 6539000000
6,457 6457000000
6,320 6320000000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
13,174 13174000000
12,301 12301000000
11,296 11296000000
11,353 11353000000
6,870 6870000000
6,539 6539000000
6,457 6457000000
6,320 6320000000
Total Liabilities & Equity
n/a
27,139 27139000000
25,177 25177000000
22,128 22128000000
21,290 21290000000
17,154 17154000000
16,571 16571000000
17,024 17024000000
18,133 18133000000
Remarks restated on n/a restated on Feb 26, 2010 n/a restated on Feb 17, 2011 n/a restated on Feb 17, 2012 n/a restated on Feb 22, 2013 n/a restated on Feb 26, 2014 n/a restated on Feb 25, 2015 n/a restated on Feb 24, 2016 n/a restated on Aug 3, 2016 n/a
Cash Flow StatementCF data quality: 24% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-495
-2,036
-1,025
-1,065
441
-4,068
-121
-119
-239
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
918
864
834
816
717
683
689
725
769
Non-Cash Items
486
2,457
101
1,947
87
4,361
359
-299
-210
Stock-Based Compensation
122
138
144
150
128
108
105
103
107
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
364
2,319
-43
1,797
-41
4,253
254
-402
-317
Change in Working Capital
25
-69
925
-1,373
-237
304
183
962
280
(Increase) Decrease in Accounts Receivable
-72
96
1
52
42
37
-101
53
-17
(Increase) Decrease in Inventories
-30
-120
-92
-5
-54
66
-7
-81
3
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
127
-45
1,016
-1,420
-225
201
291
990
294
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
934
1,216
835
325
1,008
1,280
1,110
1,269
600
Change in Fixed Assets & Intangibles
-333
-360
-307
-267
-288
-210
-192
-259
-247
Disposition of Fixed Assets & Intangibles
30
2
5
5
16
16
53
0
0
Disposition of Fixed Assets
30
2
5
5
16
16
53
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
-363
-362
-312
-272
-304
-226
-245
-259
-247
Purchase of Fixed Assets
-363
-362
-312
-272
-304
-226
-245
-259
-247
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-13
1,266
-4
-199
1,070
-356
-244
-474
-1,734
Net Cash from Divestitures
0
1,287
0
0
1,440
10
30
12
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
-13
-21
-4
-199
-370
-366
-274
-486
-1,734
Other Investing Activities
120
93
41
-2
-6
-13
-39
-12
-205
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-226
999
-270
-468
776
-579
-475
-745
-2,186
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-754
-1,425
-853
-527
-1,250
-19
-10
0
1,430
Cash From (Repayment of) Short Term Debt, net
0
-250
0
0
0
-9
0
0
0
Cash From (Repayment of) Long Term Debt, net
-754
-1,175
-853
-527
-1,250
-10
-10
0
1,430
Repayments of Long Term Debt
-1,000
-1,175
-2,825
-1,500
-1,250
-10
-1,450
0
-1,150
Cash From Long Term Debt
246
0
1,972
973
0
0
1,440
0
2,580
Cash From (Repurchase of) Equity
132
71
33
31
-471
-579
-426
-65
114
Increase in Capital Stock
132
71
33
31
21
21
74
60
114
Decrease in Capital Stock
0
0
0
0
-492
-600
-500
-125
0
Other Financing Activities
-306
-671
-523
-12
-7
-166
-188
-85
-222
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-928
-2,025
-1,343
-508
-1,728
-764
-624
-150
1,322
Net Cash Before Disc. Operations and FX
-220
190
-778
-651
56
-63
11
374
-264
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-220
190
-778
-651
56
-63
11
374
-264
Effect of Foreign Exchange Rates
4
-1
1
0
-2
3
-1
-4
-4
Net Changes in Cash
-216
189
-777
-651
54
-60
10
370
-268
Remarks
restated on Feb 26, 2010 n/a
calculated values,
restated on Feb 17, 2011 n/a
calculated values,
restated on Feb 17, 2012 n/a
calculated values,
restated on Feb 22, 2013 n/a
calculated values,
restated on Feb 26, 2014 n/a
calculated values,
restated on Feb 25, 2015 n/a
calculated values,
restated on Feb 24, 2016 n/a
calculated values,
restated on Feb 24, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo